News About: Pharm. Industry
Green Cross opens web site for placenta preparationsGreen Cross Corporation has announced its website for two placenta injections Laennec (placenta hydrosate) and Greenpla (placenta extract).
Website visitors may identify the...
|
Patents for 37 original drugs to be expired in 2010
Patents for 37 new medicines, including Fosamax, will last until 2010, according to data released by the Korea Pharmaceutical Manufacturers Association.
According to pharmaceutical business sources, domestic drug m...
Dong-A Pharm signs $58 million Zydena export dealLocal drug maker Dong-A Pharmaceutical has signed a contract with 19 countries - B.L.HUA of Thailand ($15 million), Otechestvennye JSC of Russia ($20 million), Hikma of Jordan p...
|
Ildong inked with NBP Pharmaceutical to introduce China's first class new medicineIldong Pharm has signed an exclusive license agreement with ShiJiaZhuang Pharma Group NBP Pharmaceutical Co. in Peking to distribute in Korea Butylphthalide soft capsule (3-nbut...
|
19 pharmaceutical firms open 41 subsidiaries overseas
The nation's 14 pharmaceutical manufacturers have set up a total of 14 foreign branches as pat of strategies to expand into overseas markets, according to data released by the Korea Pharmaceutical Manufacturers ...
Output of multinationals showing sluggish trends for 5 years
The Korea Pharmaceutical Manufacturers Association says that it recently analyzed drug output trends for the past five years for foreign-invested pharmaceutical firms and found that their annual output sizes have ...
Green Cross to export varicella vaccines to Croatia
Green Cross Corporation (GCC) says it has recently signed a memorandum of understanding with Imunoloski Zavod (IMZ) of Croatia, or Institute of Immunology, to export varicella vaccines to the Eastern European country ...
Some drug wholesalers urged to improve fair business practices
The Korean Pharmaceutical Association advised some drug wholesalers to rectify its business practices involving the alleged rebates to hospitals.
In a policy-making proposal delivered to presidential hopefuls on No...
Bidding war to kick off for National Cancer Center
The first hospital bidding war is expected to heat up as the state-run National Cancer Center at Ilsan will put out its bidding list for medicines on November 7.
A number of domestic pharmaceutical firms, includin...
Co-develop anti-L1 monoclonal antibody therapeutic for treating cancer
Celltrion Inc. and German biotech company MediGene AG signed a binding memorandum of understanding for the co-development and commercialization of an anti-L1 monoclonal antibody (anti-L1 MAb) for the treatment of canc...
